IBB.US iShares Biotechnology ETF
- Total assets
- 11.4B
- Expense ratio
- 0.46%
- Dividend yield
- 0.16%
- 1-year return
- +33.04%
- Holdings
- 236
- Since
- 2001
Fund data as reported by the issuer, updated Nov 15, 2026. Total assets are in the fund's base currency.
What does IBB.US invest in?
- Mostly US stocks (95.5%)
- Largest sector: Healthcare (100.0%)
- Largest region: North America (92.1%)
- Top 3 holdings: 25.4% of the fund
Asset allocation
- US stocks 95.5%
- Non-US stocks 5.9%
- Cash 0.1%
Top holdings
- Gilead Sciences Inc 9.35%
- Amgen Inc 8.52%
- Vertex Pharmaceuticals Inc 7.55%
- Regeneron Pharmaceuticals Inc 6.74%
- Moderna Inc 5.59%
iShares Biotechnology ETF performance
Sharpe ratio 1.03- This year
- +27.90%
- 1 year
- +33.04%
- 3 years
- +23.63%
- 5 years
- +7.39%
Volatility 18.4% over 1 year and 18.6% over 3 years. Moderate, similar to a broad stock index.
Total returns in the fund's currency as reported by the issuer; past returns do not predict future returns. Volatility is the yearly standard deviation of returns. Ask AI to explain these numbers
IBB.US price
Prices on the chart can differ slightly from the closing prices StockSummer shows.
About iShares Biotechnology ETF
The fund generally will invest at least 80% of its assets in the component securities of its underlying index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. It is non-diversified.
Full fund profileiShares Biotechnology ETF top holdings
51.7% of the fund| Holding | Sector | Country | Weight |
|---|---|---|---|
| Gilead Sciences Inc GILD.US | Healthcare | United States | 9.35% |
| Amgen Inc AMGN.US | Healthcare | United States | 8.52% |
| Vertex Pharmaceuticals Inc VRTX.US | Healthcare | United States | 7.55% |
| Regeneron Pharmaceuticals Inc REGN.US | Healthcare | United States | 6.74% |
| Moderna Inc MRNA.US | Healthcare | United States | 5.59% |
| argenx NV ADR ARGX.US | Healthcare | United States | 3.78% |
| Natera Inc NTRA.US | Healthcare | United States | 2.86% |
| Biogen Inc BIIB.US | Healthcare | United States | 2.55% |
| Revolution Medicines Inc RVMD.US | Healthcare | United States | 2.42% |
| BeOne Medicines AG ONC.US | Healthcare | United States | 2.36% |
The 10 largest of 236 holdings.
IBB.US sector exposure
- Healthcare100.0%
Share of the stocks in the fund.
IBB.US regional exposure
- North America92.1%
- Europe Developed3.5%
- United Kingdom1.7%
- Asia Emerging0.2%
- Australasia0.1%
- Asia Developed0.0%
Share of the stocks in the fund.
Company size
Average market cap 34.1B- Big cap35.3%
- Medium cap33.7%
- Small cap20.7%
- Micro cap8.2%
iShares Biotechnology ETF fund profile
- Fund name
- iShares Biotechnology ETF
- Ticker
- IBB.US
- Exchange
- USA Stocks
- Issuer
- iShares
- Index tracked
- -
- Category
- Healthcare Equity
- Domicile
- United States
- Inception date
- Feb 5, 2001
- Trading currency
- USD
- Expense ratio
- 0.46%
- Annual turnover
- 0.1%
About iShares Biotechnology ETF
The fund generally will invest at least 80% of its assets in the component securities of its underlying index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. It is non-diversified.